COVID-19: before the fall, an evidence-based narrative review of treatment options
Abstract The 2019 novel coronavirus (COVID-19) has quickly become one of the most dire
international pandemic crises since the 1918 Spanish flu. Evidence for COVID-19 …
international pandemic crises since the 1918 Spanish flu. Evidence for COVID-19 …
Therapeutic options for Coronavirus Disease 2019 (COVID-19): where are we now?
EY Golnabi, JM Sanders, ML Johns, K Lin… - Current Infectious …, 2021 - Springer
Abstract Purpose of Review Rapidly evolving treatment paradigms of coronavirus disease
2019 (COVID-19) introduce challenges for clinicians to keep up with the pace of published …
2019 (COVID-19) introduce challenges for clinicians to keep up with the pace of published …
Old and re-purposed drugs for the treatment of COVID-19
SS Jean, PR Hsueh - Expert review of anti-infective therapy, 2020 - Taylor & Francis
Introduction: The coronavirus disease 2019 (COVID-19) caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It …
COVID-19: An Update on the Latest Therapeutic Agents
The COVID-19 pandemic has plagued the world for over three years since discovering the
causative virus, SARS-CoV-2, in China. The rampant spread of the virus led to the loss of …
causative virus, SARS-CoV-2, in China. The rampant spread of the virus led to the loss of …
Therapeutic strategies for COVID-19: progress and lessons learned
G Li, R Hilgenfeld, R Whitley, E De Clercq - Nature Reviews Drug …, 2023 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …
Is there any potential management against COVID-19? A systematic review and meta-analysis
Purpose A recent survey has shown that the COVID-19 pandemic has culminated in
dramatical and critical treatment particularly in acute infected patients. In fact, this systematic …
dramatical and critical treatment particularly in acute infected patients. In fact, this systematic …
Current evidence for COVID-19 therapies: a systematic literature review
T Welte, LJ Ambrose, GC Sibbring… - European …, 2021 - Eur Respiratory Soc
Effective therapeutic interventions for the treatment and prevention of coronavirus disease
2019 (COVID-19) are urgently needed. A systematic review was conducted to identify …
2019 (COVID-19) are urgently needed. A systematic review was conducted to identify …
Potential therapeutic options for COVID-19: current status, challenges, and future perspectives
C Sarkar, M Mondal, M Torequl Islam… - Frontiers in …, 2020 - frontiersin.org
The COVID-19 pandemic represents an unprecedented challenge for the researchers to
offer safe, tolerable, and effective treatment strategies for its causative agent known as …
offer safe, tolerable, and effective treatment strategies for its causative agent known as …
An update on current therapeutic drugs treating COVID-19
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
Review of registered clinical trials for the treatment of COVID‐19
Abstract Coronavirus disease 2019 (COVID‐19) is a viral disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The disease was first reported in …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The disease was first reported in …